Lv11
10 积分 2024-06-14 加入
Albubody: an engineered scFv variant platform for site-specific drug conjugation and enhanced tumor efficacy
5小时前
待确认
Characterization of anti-CD3 antibodies in clinically available bispecific T cell engagers
2个月前
已完结
Claudin 18.2 is a target for IMAB362 antibody in pancreatic neoplasms
2个月前
已完结
Molecular pathogenesis, targeted therapies, and future perspectives for gastric cancer
2个月前
已完结
Liquid biopsy in B and T cell lymphomas: from bench to bedside
2个月前
已完结
A CLDN18.2-target⁃ing bispecific T cell Co-stimulatory activator for cancer immuno⁃therapy
2个月前
已完结
The claudin-18.2-CD3 bispecific antibody IBI389 exerts an antitumor effect on malignant tumors with positive claudin-18.2 expression by promoting T-cell infiltration and remodeling the tumor immune microenvironment
2个月前
已完结
Structure-based calculation of excipient effects on the viscosity of concentrated antibody solutions
5个月前
已完结
皖公网安备34019202002308
